CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE:CLSH), a diversified cannabis company operating as Cannabis Life Sciences, announced that following receipt of the requisite approval of debenture holders and the Canadian Securities Exchange, it has amended the terms of its outstanding $13.2 million principal amount unsecured convertible debentures issued December 12, 2018 by, among other things:

Full story available on Benzinga.com